Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. 1993

E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
Department of Internal Medicine, Herlev Hospital, University of Copenhagen, Denmark.

beta-Cell function and glucose metabolism were studied in eight insulin-dependent diabetic recipients of combined segmental pancreas and kidney transplant with peripheral insulin delivery (Px), in eight nondiabetic kidney-transplant individuals (Kx), and in eight normal subjects (Ns) after three consecutive mixed meals. All subjects had normal fasting plasma glucose, but increased basal levels of C-peptide were demonstrated in the transplant groups (P < 0.05 relative to Ns). Postprandial hyperglycemia was increased 14% in Kx and 32% in Px (P < 0.05), whereas compared with Ns postprandial C-peptide levels were increased three- and twofold, respectively, in Kx and Px (P < 0.05). Compared with Ns basal insulin secretion rate (combined model) was increased 2-fold in Kx and 1.4-fold in Px (P < 0.05). Maximal insulin secretion rate was reduced 25% in Px compared with Kx (P < 0.05) but not different from that of Ns (P NS). Also, maximal insulin secretion rate occurred later in Px than in controls (Tmax: Px 50 min, Kx 30 min, and Ns 32 min; P < 0.05). The total integrated insulin secretion was increased 1.4-fold in Px compared with Ns (P < 0.05) but decreased 1.4-fold compared with Kx (P < 0.05). Fasting and postprandial proinsulin-to-C-peptide molar ratios were inappropriately increased in Px compared with Kx and Ns. Basal hepatic glucose production was increased 43% in Px and 33% in Kx compared with Ns (P < 0.05). Postprandial total systemic glucose appearance was similar in all three groups, whereas peripheral glucose disposal was 15% reduced in Px (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
February 1987, Transplantation proceedings,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
August 2008, Current diabetes reports,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
November 1996, The Journal of clinical endocrinology and metabolism,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
April 1990, Transplantation proceedings,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
May 1993, The Journal of clinical endocrinology and metabolism,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
April 1984, World journal of surgery,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
June 2009, Current opinion in lipidology,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
February 1987, The Netherlands journal of surgery,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
January 2011, Jornal brasileiro de nefrologia,
E Christiansen, and H B Andersen, and K Rasmussen, and N J Christensen, and K Olgaard, and P Kirkegaard, and B Tronier, and A Vølund, and P Damsbo, and F Burcharth
November 1997, Transplantation proceedings,
Copied contents to your clipboard!